SEC
CDLX icon

Seven Eight Capital’s Cardlytics CDLX Stock Holding History

Seven Eight Capital’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,800
Closed -$979K – 351
2020
Q1 		$979K Sell
2,800
-1,010
-27% -$715K 0.25% 119
2019
Q4 		$2.4M Buy
+3,810
New +$1.86M 0.13% 249

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Seven Eight Capital's CDLX Position: Q2 2020 in Review

Seven Eight Capital sold out of Cardlytics (CDLX) in Q2 2020, closing a stake of 2,800 shares — an estimated $979K sold.

Seven Eight Capital first reported a position in CDLX in Q4 2019 and held it in 2 quarters. The position peaked at $2.4M in Q4 2019. 164 funds tracked by Wall St. Rank hold CDLX as of Q2 2020.

  • Seven Eight Capital reported no remaining Cardlytics position as of Q2 2020 after selling out during the quarter.
  • Seven Eight Capital sold 2,800 Cardlytics shares in Q2 2020, an estimated $979K.
  • Seven Eight Capital first reported a position in Cardlytics in Q4 2019 and held it in 2 quarters.
  • Seven Eight Capital's Cardlytics position peaked at $2.4M in Q4 2019.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q2 2020.

Based on Seven Eight Capital's 13F filing for Q2 2020, filed 6 Aug 2020.